APA (7th ed.) Citation

Sorokin, M., Ignatev, K., Barbara, V., Vladimirova, U., Muraveva, A., Suntsova, M., . . . Buzdin, A. (2020). Molecular Pathway Activation Markers Are Associated with Efficacy of Trastuzumab Therapy in Metastatic HER2-Positive Breast Cancer Better than Individual Gene Expression Levels. Biochemistry (Moscow), 85(7), 758. https://doi.org/10.1134/S0006297920070044

Chicago Style (17th ed.) Citation

Sorokin, M., et al. "Molecular Pathway Activation Markers Are Associated with Efficacy of Trastuzumab Therapy in Metastatic HER2-Positive Breast Cancer Better than Individual Gene Expression Levels." Biochemistry (Moscow) 85, no. 7 (2020): 758. https://doi.org/10.1134/S0006297920070044.

MLA (9th ed.) Citation

Sorokin, M., et al. "Molecular Pathway Activation Markers Are Associated with Efficacy of Trastuzumab Therapy in Metastatic HER2-Positive Breast Cancer Better than Individual Gene Expression Levels." Biochemistry (Moscow), vol. 85, no. 7, 2020, p. 758, https://doi.org/10.1134/S0006297920070044.